S4049 Severe Immunosuppression Revealing High-Grade B-Cell Lymphoma in a Patient With Untreated HIV

Introduction: HIV infection, if untreated, can lead to significant immunosuppression, ultimately predisposing patients to opportunistic infections and AIDS-defining malignancies such as high-grade B-cell lymphoma. Nonspecific symptoms may be the initial presentation of a serious underlying process. We present a case of newly diagnosed AIDS with gastrointestinal lymphoma, which was initially suspected to be inflammatory bowel disease, as well as opportunistic esophageal candidiasis. Case Description/Methods: A 31-year-old man with a history of untreated HIV presented with abdominal pain, unintentional weight loss and occasional night sweats. Initial labs revealed hemoglobin 5.6 g/dL, mean corpuscular volume 84.9 fL, and he received 2 units of packed red blood cells. Stool pathogen panel was negative, and fecal calprotectin was not elevated. Erythrocyte sedimentation rate and C-reactive protein were 27 mm/hr and 74 mg/L, respectively. HIV screen showed a positive antibody with a negative p24 antigen. CD4 count was 12 cells/μL, and HIV viral load was 155,000 copies/mL. Computed tomography abdomen/pelvis showed marked wall thickening of the ascending, hepatic flexure and transverse colon with pericolonic fat stranding. Magnetic resonance imaging abdomen showed diffuse colitis. Colonoscopy revealed circumferential ulceration and mass-like lesions in the transverse and descending colon, raising concern for colocolonic fistulizing Crohn disease. Biopsies demonstrated high-grade B-cell lymphoma. Esophagogastroduodenoscopy showed patchy white plaques throughout the esophagus with biopsy confirming esophageal candidiasis. The patient was empirically started on intravenous (IV) ceftriaxone, metronidazole and fluconazole. HAART was initiated along with trimethoprim-sulfamethoxazole for primary prophylaxis of pneumocystis pneumonia. Due to his immunocompromised state, he was deemed a poor surgical candidate. Oncology was consulted and initiated treatment with R-CHOP. He was discharged with close follow-up plans for chemotherapy and HIV management. Discussion: This case demonstrates the importance of keeping a broad differential when evaluating gastrointestinal symptoms in patients with newly diagnosed or untreated HIV, as severe immunosuppression can mimic or mask other diseases. In this case, findings that were initially concerning for inflammatory bowel disease were actually indicative of underlying malignancy. Prompt recognition, early treatment, and multidisciplinary care are critical in preventing and managing AIDS-related complications, as well as improving patient outcomes.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001143656.71477.ae
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4049 Severe Immunosuppression Revealing High-Grade B-Cell Lymphoma in a Patient With Untreated HIV

Lirio Polintan, Ahmad Zain, Ajay M. Shah, Mena Tawfik
The American Journal of Gastroenterology
Viral-associated cancers and disorders
article

S4049 Severe Immunosuppression Revealing High-Grade B-Cell Lymphoma in a Patient With Untreated HIV

Lirio Polintan, Ahmad Zain, Ajay M. Shah, Mena Tawfik
article en

Abstract

Introduction: HIV infection, if untreated, can lead to significant immunosuppression, ultimately predisposing patients to opportunistic infections and AIDS-defining malignancies such as high-grade B-cell lymphoma. Nonspecific symptoms may be the initial presentation of a serious underlying process. We present a case of newly diagnosed AIDS with gastrointestinal lymphoma, which was initially suspected to be inflammatory bowel disease, as well as opportunistic esophageal candidiasis. Case Description/Methods: A 31-year-old man with a history of untreated HIV presented with abdominal pain, unintentional weight loss and occasional night sweats. Initial labs revealed hemoglobin 5.6 g/dL, mean corpuscular volume 84.9 fL, and he received 2 units of packed red blood cells. Stool pathogen panel was negative, and fecal calprotectin was not elevated. Erythrocyte sedimentation rate and C-reactive protein were 27 mm/hr and 74 mg/L, respectively. HIV screen showed a positive antibody with a negative p24 antigen. CD4 count was 12 cells/μL, and HIV viral load was 155,000 copies/mL. Computed tomography abdomen/pelvis showed marked wall thickening of the ascending, hepatic flexure and transverse colon with pericolonic fat stranding. Magnetic resonance imaging abdomen showed diffuse colitis. Colonoscopy revealed circumferential ulceration and mass-like lesions in the transverse and descending colon, raising concern for colocolonic fistulizing Crohn disease. Biopsies demonstrated high-grade B-cell lymphoma. Esophagogastroduodenoscopy showed patchy white plaques throughout the esophagus with biopsy confirming esophageal candidiasis. The patient was empirically started on intravenous (IV) ceftriaxone, metronidazole and fluconazole. HAART was initiated along with trimethoprim-sulfamethoxazole for primary prophylaxis of pneumocystis pneumonia. Due to his immunocompromised state, he was deemed a poor surgical candidate. Oncology was consulted and initiated treatment with R-CHOP. He was discharged with close follow-up plans for chemotherapy and HIV management. Discussion: This case demonstrates the importance of keeping a broad differential when evaluating gastrointestinal symptoms in patients with newly diagnosed or untreated HIV, as severe immunosuppression can mimic or mask other diseases. In this case, findings that were initially concerning for inflammatory bowel disease were actually indicative of underlying malignancy. Prompt recognition, early treatment, and multidisciplinary care are critical in preventing and managing AIDS-related complications, as well as improving patient outcomes.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 54%
Viral-associated cancers and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.